Biotechnology firm Antigenics Inc. said Tuesday its treatment for kidney cancer received regulatory approval in Russia, the first in any country for the cancer vaccine.
Shares rose to $3.55 during premarket trading from Monday's close of $ [...]
Posted On : Apr, 09 2008 | Comments : 0